Stockpickrs~
Keep your eyes on ULU (Uluru). This company is in transition from being a
research company to a commercial company. They have 3 patented technologies
that will save money and production in wound care.
Recent developements are:
1. Appointed Mr. Ronald Athens, to be Director of the company. At age 67, Mr.
Athens has been an advisor to Merck, since 1995 when he retired as President of
Merck Consumer Healthcare Worldwide, previously he was Exec. Vice-President of
Consumer Health Care Int'l. He also worked as Consumer Group President, N.
America of Bristol-Meyers Squibb. Prior to 1985, he worked with Richardson
Vicks and Proctor and Gamble. His expertise will add greatly to ULU.
2. Royce and Associates bought 10.97%
3. Janus Partners increases its stakes in ULU to 14.5% from 9%.
4. Conference call today: July 9th at 10 a.m.
1-800-357-0498 (access code #9294).
Remember, regardless of who is in the White House, they both will be looking at
reducing medical costs.

Please take a look at this stock!
Good luck!
Kathy in NJ